Sublingual immunotherapy for pediatric allergic conjunctivitis: a meta-analysis of randomized controlled trials

被引:15
作者
Yang, Jie [1 ]
Zhang, Li [2 ]
Zhao, Zhixiang [3 ]
Liao, Shiyu [3 ]
机构
[1] Zhejiang Hosp, Dept Ophthalmol, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Dept Ophthalmol, Sch Med, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Hosp, Dept Otorhinolaryngol, Lingyin Rd 12, Hangzhou 310013, Zhejiang, Peoples R China
关键词
sublingual immunotherapy; pediatric; allergy; conjunctivitis; meta-analysis; HOUSE-DUST MITE; PLACEBO-CONTROLLED EVALUATION; DOUBLE-BLIND; SWALLOW IMMUNOTHERAPY; POLLEN EXTRACT; GRASS-POLLEN; CHILDREN; EFFICACY; RHINOCONJUNCTIVITIS; RHINITIS;
D O I
10.1002/alr.22149
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Methods Allergic conjunctivitis (AC) is a common chronic condition, especially in children. Ocular symptoms are often overlooked during treatment of allergic rhinoconjunctivitis (ARC). Pediatric ARC can be effectively treated using sublingual immunotherapy (SLIT), which is a guideline-recommended safe treatment approach. However, the therapeutic efficacy of SLIT in terms of ameliorating eye symptoms has not been effectively evaluated. We performed a meta-analysis of randomized controlled trials (RCTs) evaluating the use of SLIT for infants, children, and adolescents (aged from 3 to 18 years) with AC or ARC. We searched the Cochrane Library database, EMBASE, and Medline from November 1990 to 2017 to find papers dealing with the effects of SLIT on pediatric AC or ARC. We used standardized mean differences (SMDs) to assess therapeutic effects, employing a random effects model. Subgroup and sensitivity analyses were also conducted. The I-2 metric was used to evaluate heterogeneity. Results Conclusion In total, 13 clinical RCTs were included in our meta-analysis. SLIT reduced ocular symptoms to a level below that of controls (SMD = -0.21; 95% confidence interval [CI], -0.41 to -0.01; p = 0.04; I-2 = 55%). Notably, on subgroup analysis, SLIT clearly reduced pollen-induced pediatric AC (SMD = -0.36; 95% CI, -0.53 to -0.19; p < 0.0001; I-2 = 25%) but not mite-induced AC (SMD = 0.20; 95% CI, -0.20 to 0.60; p = 0.34; I-2 = 46%). SLIT relieved ocular symptoms in children with ARC or AC. To confirm these results, future meta-analyses should evaluate high-quality, large-scale population-based trials.
引用
收藏
页码:1253 / 1259
页数:7
相关论文
共 30 条
  • [1] Advances in pharmacotherapy for allergic conjunctivitis
    Abelson, Mark B.
    Shetty, Sirikishan
    Korchak, Michael
    Butrus, Salim I.
    Smith, Lisa M.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (08) : 1219 - 1231
  • [2] Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: A double-blind-placebo-controlled randomised trial
    Aydogan, Metin
    Eifan, Aarif O.
    Keles, Sevgi
    Akkoc, Tunc
    Nursoy, Mustafa A.
    Bahceciler, Nerrin N.
    Barlan, Isil B.
    [J]. RESPIRATORY MEDICINE, 2013, 107 (09) : 1322 - 1329
  • [3] Bielory Leonard, 2007, MedGenMed, V9, P35
  • [4] Ocular allergy overview
    Bielory, Leonard
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2008, 28 (01) : 1 - 23
  • [5] Differential diagnoses of conjunctivitis for clinical allergist-immunologists
    Bielory, Leonard
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (02) : 105 - 115
  • [6] Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy
    Bufe, Albrecht
    Eberle, Peter
    Franke-Beckmann, Eivy
    Funck, Juergen
    Kimmig, Martin
    Klimek, Ludger
    Knecht, Roland
    Stephan, Volker
    Tholstrup, Bente
    Weisshaar, Christian
    Kaiser, Friedrich
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (01) : 167 - 173
  • [7] Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial
    Caffarelli, C
    Sensi, LG
    Marcucci, F
    Cavagni, G
    [J]. ALLERGY, 2000, 55 (12) : 1142 - 1147
  • [8] Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis
    Calderon, M. A.
    Penagos, M.
    Sheikh, A.
    Canonica, G. W.
    Durham, S. R.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (09) : 1263 - 1272
  • [9] Canonica GW, 2009, ALLERGY, V64, P1, DOI 10.1111/j.1398-9995.2009.02309.x
  • [10] Sublingual immunotherapy not effective in house dust mite-allergic children in primary care
    de Bot, Cindy M. A.
    Moed, Heleen
    Berger, Marjolein Y.
    Roder, Esther
    Hop, Wim C. J.
    de Groot, Hans
    de Jongste, Johan C.
    van Wijk, Roy Gerth
    Bindels, Patrick J. E.
    van der Wouden, Johannes C.
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2012, 23 (02) : 151 - 159